Ackman Made a 'Valiant' Effort, Time to Move On: Herbalife (HLF)

Go back to Ackman Made a 'Valiant' Effort, Time to Move On: Herbalife (HLF)

Herbalife (HLF) Has 'Levers to Pull' in Next Few Weeks - Pivotal Research

July 18, 2016 9:40 AM EDT

Pivotal Research reiterated a Buy rating on Herbalife (NYSE: HLF) with a price target of $90. Analyst Timothy S. Ramey doesn't believe efforts to comply with FTC oversight will do much damage to its U.S. business, and he reiterated his bullish stance. He also noted that Herbalife has "several important levers to pull in the next few weeks."

"There is no doubt that the permanent injunction, entered into by the FTC and Herbalife has challenges for the company and plenty of stern language. The company will be under three-year scrutiny by the... More

Herbalife (HLF) Enters Settlement with FTC; Board Grants Icahn Ability to Boost Stake to 34.99%

July 15, 2016 8:28 AM EDT

Herbalife Ltd. (NYSE: HLF) announced it has reached a settlement agreement with the Federal Trade Commission (FTC or the Commission) resolving the FTCs multi-year investigation of the Company. The terms of the settlement do not change Herbalifes business model as a direct selling company and set new standards for the industry. With the settlement agreement announced today, the FTCs investigation of Herbalife is complete.

Herbalife and the Illinois Attorney General also reached a settlement, and the Company agreed to pay $3 million as part of this separate agreement. With the conclusion of the... More

Bill Ackman Will Be on CNBC's Halftime Report Today (VRX) (HLF)

July 14, 2016 8:55 AM EDT

Bill Ackman will be on CNBC's Halftime Report at noon. Although the agenda wasn't disclosed, he will likely discuss Herbalife (NYSE: HLF) and Valeant Pharma (NYSE: VRX).

Today on @HalftimeReport at noon ET: Bill Ackman joins @ScottWapnerCNBC and the traders LIVE pic.twitter.com/kGGLLRrzmO

CNBC Now (@CNBCnow) July 14, 2016... More